◀ Back to JUN
HDAC2 — JUN
Protein-Protein interactions - manually collected from original source literature:
Studies that report less than 10 interactions are marked with *
-
Gene Ontology Complexes transcriptional repressor complex:
transcriptional repressor complex complex (ELANE-HDAC2-LIN37-CDX2-N4BP2L2-CBX5-C1D-SKI-JUN-GLI3-YWHAB-HDGF-RLIM-SIN3A-ZNF224-MIER1-CORO2A-GFI1-ETV3-DDX20-AKIRIN2-LIN9-INSM1-CTBP2)
Ostendorff et al., Genomics 2000, Ding et al., Mol Cell Biol 2003, Yoon et al., EMBO J 2003, McGhee et al., J Cell Biochem 2003, Liu et al., Biochem J 2006, Wang et al., J Endocrinol 2008, Yang et al., J Mol Biol 2009, Salipante et al., Mol Cell Biol 2009, Harada et al., Cancer Res 2010
-
Gene Ontology Complexes transcription factor complex:
transcription factor complex complex (ATF7IP-GSC-GCM1-MAFB-NKX2-1-NKX2-5-RARG-KLF4-FOXF1-FOXF2-FOXE3-LDB1-ZFHX3-GATA6-SNAI3-FOXH1-KAT5-AHR-EYA3-NFATC2-CRX-MED27-HES6-SKI-XRCC6-ARNTL-SUB1-JUN-SOX17-SCX-DMBX1-TCF4-TCF7-PDLIM1-TFEB-LBX1-TRRAP-NAA16-EPAS1-MGA-PTF1A-HOXD12-MEF2B-TFDP3-TFDP1-HDAC2-YY1-SMAD9-CLOCK-ONECUT3-SMAD5-SMAD6-SMAD7-SMAD1-SMAD2-PRKDC-RCOR2-NHLH2-REL-TBX5-ARNTL2-BSX-HOXA10-HOXB13-MED23-PUS1-TAL1-RBL1-RBL2-MINA-HMGA1-BARX2-LEF1-EP300-PMF1-ARID5A-WWTR1-LMO2-LMO4-TP73-ABT1-CDK2-DKFZp686M216-CREG1-CTNNB1-SOX9-HAND2-SOX2-TEAD2-MYOG-TEAD4-CEBPA-GFI1B-MYOD1-ALX1-NPAS4-TFAP2D-FIGLA-ALX4-ETS1-PROP1-ASCL3-HCLS1-MSX1-MSX2-SRA1-AJUBA-MTA2-SIN3A-POU3F2-POU3F1-BEX1-MLXIPL-NR2E3-PBX2-ANKRD1-E2F6-E2F5-E2F4-E2F3-E2F2-E2F1-E2F8-CREBBP-ATF5-ATF4-POU2F3)
Kaspar et al., J Biol Chem 1999, Wang et al., J Biol Chem 1999, Nagpal et al., J Biol Chem 1999, Blixt et al., Genes Dev 2000, Carlberg et al., Mol Cell Biol Res Commun 2000, Bae et al., Development 2000, Cairo et al., Hum Mol Genet 2001, Tutter et al., Genes Dev 2001, Willis et al., J Biol Chem 2002, Bayne et al., Mol Hum Reprod 2004, Schubert et al., J Biol Chem 2004, Han et al., J Mol Biol 2005, Rodriguez et al., EMBO J 2005, Han et al., Nucleic Acids Res 2005, Zhang et al., Mol Cell Biol 2007, Wong et al., Cell 2009, Stevens et al., Immunology 2009, Stefanovic et al., J Cell Biol 2009, Skokowa et al., Nat Med 2012, Ge et al., Cell 1994, Durocher et al., EMBO J 1997, Hogenesch et al., Proc Natl Acad Sci U S A 1998, Hellqvist et al., J Biol Chem 1998, Ryu et al., Nature 1999
Text-mined interactions from Literome
Rahman et al., Biochem Pharmacol 2002
(Pneumonia) :
Pharmacological inhibition of
HDAC leads to the increased HAT activity,
AP-1 and NF-kappaB activation, and IL-8 release by H2O2 or TNF-alpha treatments
Yamaguchi et al., J Biol Chem 2005
:
Chromatin immunoprecipitation assays indicated that
HDAC inhibitors
suppressed c-Jun binding to the COX-2 promoter and thereby blocked transcription
Wang et al., J Biol Chem 2006
:
In this study, we found that
c-Jun NH2-terminal kinase 1 activation
triggered CtBP phosphorylation on Ser-422 and subsequent degradation, inducing p53 independent apoptosis in human lung cancer cells
Huang et al., J Cell Physiol 2009
(Leukemia, Myelogenous, Chronic, BCR-ABL Positive) :
Moreover,
c-Jun did not alter growth inhibition and apoptotic induction by histone deacetylase (HDAC) inhibitors ( apicidin, sodium butyrate, and MS275 ) treatment, but
inhibited HDAC inhibitors induced erythroid differentiation
Farhana et al., Mol Cancer Ther 2009
:
SHP and
Sin3A expression are
essential for adamantyl substituted retinoid related molecule mediated nuclear factor-kappaB activation,
c-Fos/c-Jun expression, and cellular apoptosis ... We examined the
effect of loss of SHP and
Sin3A expression in a number of cell types on 3-Cl-AHPC mediated growth inhibition and apoptosis induction, 3-Cl-AHPC mediated nuclear factor-kappaB (NF-kappaB) activation, and 3-Cl-AHPC mediated increase in c-Fos and
c-Jun expression
Zhou et al., Leukemia 2013
(Leukemia, Myeloid, Acute) :
We here report that inhibition of
histone deacetylase (HDAC) using the specific class I HDAC inhibitor SNDX-275
restored the expression of Nur77/Nor1 and induced expression of activator protein 1 transcription factors
c-Jun and JunB, and of death receptor TRAIL, in AML cells and in CD34 ( + ) /38 ( - ) AML LSCs. Importantly, SNDX-275 induced extensive apoptosis in AML cells, which could be suppressed by silencing nur77 and nor1